Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 64

1.

Patients lacking the major CNS myelin protein, proteolipid protein 1, develop length-dependent axonal degeneration in the absence of demyelination and inflammation.

Garbern JY, Yool DA, Moore GJ, Wilds IB, Faulk MW, Klugmann M, Nave KA, Sistermans EA, van der Knaap MS, Bird TD, Shy ME, Kamholz JA, Griffiths IR.

Brain. 2002 Mar;125(Pt 3):551-61.

PMID:
11872612
2.

Pelizaeus-Merzbacher disease: pathogenic mechanisms and insights into the roles of proteolipid protein 1 in the nervous system.

Garbern JY.

J Neurol Sci. 2005 Feb 15;228(2):201-3. Epub 2004 Dec 16. Review. No abstract available.

PMID:
15694206
3.

Pelizaeus-Merzbacher disease: Genetic and cellular pathogenesis.

Garbern JY.

Cell Mol Life Sci. 2007 Jan;64(1):50-65. Review.

PMID:
17115121
4.

The molecular and cellular defects underlying Pelizaeus-Merzbacher disease.

Woodward KJ.

Expert Rev Mol Med. 2008 May 19;10:e14. doi: 10.1017/S1462399408000677. Review.

PMID:
18485258
5.

Current concepts of PLP and its role in the nervous system.

Griffiths I, Klugmann M, Anderson T, Thomson C, Vouyiouklis D, Nave KA.

Microsc Res Tech. 1998 Jun 1;41(5):344-58. Review.

PMID:
9672418
6.

Imaging axonal damage in multiple sclerosis by means of MR spectroscopy.

De Stefano N, Narayanan S, Mortilla M, Guidi L, Bartolozzi ML, Federico A, Arnold DL.

Neurol Sci. 2000;21(4 Suppl 2):S883-7. Review.

PMID:
11205368
7.

The PLP mutants from mouse to man.

Duncan ID.

J Neurol Sci. 2005 Feb 15;228(2):204-5. Epub 2004 Nov 24. Review. No abstract available.

PMID:
15694207
8.

Pelizaeus-Merzbacher disease.

Koeppen AH, Robitaille Y.

J Neuropathol Exp Neurol. 2002 Sep;61(9):747-59. Review.

PMID:
12230321
9.

Axon-glial interaction in the CNS: what we have learned from mouse models of Pelizaeus-Merzbacher disease.

Gruenenfelder FI, Thomson G, Penderis J, Edgar JM.

J Anat. 2011 Jul;219(1):33-43. doi: 10.1111/j.1469-7580.2011.01363.x. Epub 2011 Mar 14. Review.

10.

Distinct phenotypes associated with increasing dosage of the PLP gene: implications for CMT1A due to PMP22 gene duplication.

Anderson TJ, Klugmann M, Thomson CE, Schneider A, Readhead C, Nave KA, Griffiths IR.

Ann N Y Acad Sci. 1999 Sep 14;883:234-46. Review.

PMID:
10586248
11.

Myelin-associated glycoprotein is a myelin signal that modulates the caliber of myelinated axons.

Yin X, Crawford TO, Griffin JW, Tu Ph, Lee VM, Li C, Roder J, Trapp BD.

J Neurosci. 1998 Mar 15;18(6):1953-62. Review.

12.

Rabbit paralytic tremor phenotype--a plp1 gene mutation as a model of human Pelizaeus-Merzbacher disease.

Sypecka J, Domańska-Janik K.

Acta Neurobiol Exp (Wars). 2005;65(2):221-9. Review.

13.

Comparison of CNS and PNS myelin proteins in the pathology of myelin disorders.

Quarles RH.

J Neurol Sci. 2005 Feb 15;228(2):187-9. Epub 2004 Dec 1. Review. No abstract available.

PMID:
15694201
14.

Pathogenesis of brain and spinal cord atrophy in multiple sclerosis.

Minagar A, Toledo EG, Alexander JS, Kelley RE.

J Neuroimaging. 2004 Jul;14(3 Suppl):5S-10S. Review.

PMID:
15228754
15.

Phylogeny of proteolipid proteins: divergence, constraints, and the evolution of novel functions in myelination and neuroprotection.

Möbius W, Patzig J, Nave KA, Werner HB.

Neuron Glia Biol. 2008 May;4(2):111-27. doi: 10.1017/S1740925X0900009X. Epub 2009 Jun 5. Review.

PMID:
19497142
16.

Demyelinating and axonal features of Charcot-Marie-Tooth disease with mutations of myelin-related proteins (PMP22, MPZ and Cx32): a clinicopathological study of 205 Japanese patients.

Hattori N, Yamamoto M, Yoshihara T, Koike H, Nakagawa M, Yoshikawa H, Ohnishi A, Hayasaka K, Onodera O, Baba M, Yasuda H, Saito T, Nakashima K, Kira J, Kaji R, Oka N, Sobue G; Study Group for Hereditary Neuropathy in Japan.

Brain. 2003 Jan;126(Pt 1):134-51. Review.

PMID:
12477701
17.

The myelin proteolipid DMα in fishes.

Brösamle C.

Neuron Glia Biol. 2010 May;6(2):109-12. doi: 10.1017/S1740925X09000131. Epub 2009 Jun 10. Review.

PMID:
19508742
18.

Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease.

Bjartmar C, Wujek JR, Trapp BD.

J Neurol Sci. 2003 Feb 15;206(2):165-71. Review.

PMID:
12559505
19.

Pelizaeus-Merzbacher disease as a chromosomal disorder.

Yamamoto T, Shimojima K.

Congenit Anom (Kyoto). 2013 Mar;53(1):3-8. doi: 10.1111/cga.12005. Review.

PMID:
23480352
20.

Axonal degeneration in the pathogenesis of multiple sclerosis.

Silber E, Sharief MK.

J Neurol Sci. 1999 Nov 15;170(1):11-8. Review.

PMID:
10540030

Supplemental Content

Support Center